The EU Joint Clinical Assessment (JCA) is expected to require considerable time and resources from both countries and ...

GSK’s fully liquid presentation of its meningococcal vaccine Menveo has been approved by the European Commission (EC) to ...

Gastric cancer is the fifth leading cause of cancer-related deaths globally and oesophageal cancer is the sixth ...

Sanofi has announced the opening of its new €558m-backed manufacturing facility in Singapore, which the company says ...

AstraZeneca (AZ) has announced positive high-level results from a late-stage study of its AKT inhibitor Truqap (capivasertib) ...

A UK study has shown that a drug currently used to treat severe asthma could be re-purposed for use in emergency settings, ...

GSK’s linerixibat has shown promising results in a late-stage trial of primary biliary cholangitis (PBC) patients with ...

Novartis’ Kisqali (ribociclib) has been approved by the European Commission (EC) to reduce the risk of disease recurrence in ...

Policymakers, payers, providers, patients and pharma are each uniquely able to impact health equity – and together, achieve ...

COP29 President-Designate around November’s global climate conference. And reviewing the insights from a recent look at how ...

Galderma’s nemolizumab has been shown to improve the core signs and symptoms of prurigo nodularis, according to phase 3 ...

The US Food and Drug Administration (FDA) has approved Shorla Oncology’s Imkeldi oral solution to treat certain forms of ...